Drug Genetic Disease

Amondys 45

Payments companies reported to CMS as associated with Amondys 45. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$128associated payments (2023-2025)
7clinicians with associated payments
1company reporting

By year

2023 $96.16
2024 $31.80

Payments reported as associated with Amondys 45, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Family $38.49
Nurse Practitioner $22.60
Pediatric Cardiology $22.60
Neurology (Psychiatry & Neurology) $15.90
Pediatrics (Nurse Practitioner) $14.19
Pediatric Emergency Medicine (Pediatrics) $14.18

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Amondys 45

These are the largest totals companies reported as associated with Amondys 45. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Peter Morelli Stony Brook, NY Pediatric Cardiology $22.60
Dawn Dawson Holbrook, NY Nurse Practitioner $22.60
Kristina Tzortzis New Hyde Park, NY Family $22.59
David Chaar Sherman, TX Neurology (Psychiatry & Neurology) $15.90
Akram Mirdamadiha Plano, TX Family $15.90
Melissa Lee Hartford, CT Pediatrics (Nurse Practitioner) $14.19
Jesse Sturm Hartford, CT Pediatric Emergency Medicine (Pediatrics) $14.18

Prescribed Amondys 45?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.